Yes, lactate levels can potentially serve as a biomarker for cancer progression and prognosis. Elevated lactate levels are often associated with more aggressive tumors and poorer outcomes. Monitoring lactate levels in patients could help in assessing the effectiveness of treatments and in making therapeutic decisions.
